← Browse by Condition
Medical Condition
hnscc
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for hnscc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — hnscc Clinical Trials
How many clinical trials are currently recruiting for hnscc?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for hnscc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hnscc?
hnscc research spans Phase 1 (5 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hnscc clinical trial?
Eligibility criteria for hnscc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06107686 Phase 2
Recruiting
Enrollment
200 pts
Location
China
Sponsor
MediLink Therapeutics (Suzhou)...
NCT07686575
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Zhujiang Hospital
NCT03526835 Phase 1, Phase 2
Recruiting
Enrollment
523 pts
Location
United States, Belgi...
Sponsor
Merus B.V.
NCT06741982 Phase 1
Recruiting
Enrollment
21 pts
Location
China
Sponsor
West China Hospital
NCT06755762
Recruiting
Enrollment
88 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07182149 Phase 1
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
Normunity AccelCo, Inc.
NCT06736379 Phase 1
Recruiting
Enrollment
41 pts
Location
United States
Sponsor
VLP Therapeutics
NCT06673693 Phase 2
Recruiting
Enrollment
24 pts
Location
China
Sponsor
Sun Yat-sen University
NCT07462377 Phase 1
Recruiting
Enrollment
110 pts
Location
United States
Sponsor
EpiBiologics
Related Conditions
nsclc (3) head and neck squamous cell carcinoma (2) head and neck cancer (2) head and neck squamous cell cancer (2) head and neck squamous cell carcinoma hnscc (2) breast cancer (1) locally advanced or metastatic solid tumors (1) oscc (1) opscc (1) ivonescimab (1) advanced metastatic solid tumors (1) colorectal cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology